PsychPartnersPsychPartners
 
PsychPartnersPsychPartners
New Patients
  • Providers & Locations
    • Providers
    • Locations
  • Self Help
    • Self Help Blog
    • Research for the Public
    • Lifestyle
    • Supplements
    • Psych Meds
    • Pocket Psychiatrist Podcast
    • Depression & Bipolar Workbook
  • Psych Education
    • Research Updates
      • Daily Psych Blog
      • Top Research
      • LinkedIn
      • Facebook
      • X
      • Bluesky
    • Books
    • Carlat Psych Podcast
    • Talks
  • Join our Team
    • Primary Care Partners
    • Therapy Partners
    • Employment
  • Contact
SSRI vs Naltrexone for Hypersexuality
AntidepressantsDisordersMedicationsResearchSexual dysfunction

SSRI vs Naltrexone for Hypersexuality

October 9, 2026by Chris Aiken, MD0
Naltrexone vs Buprenorphine for Opioid Use Disorder
DisordersOpioidsResearchSubstance Use

Naltrexone vs Buprenorphine for Opioid Use Disorder

August 27, 2026by Chris Aiken, MD0
Naltrexone’s Safety in Cirrhosis
AlcoholDisordersMed-PsychResearchSubstance Use

Naltrexone’s Safety in Cirrhosis

August 23, 2026by Chris Aiken, MD0
How Naltrexone-Bupropion Treats Meth Use Disorder
Addiction MedsDepressionDisordersMethamphetamineResearchSubstance Use

How Naltrexone-Bupropion Treats Meth Use Disorder

July 29, 2026by Chris Aiken, MD0
How to Personalize Meds for Alcohol Use Disorder
Addiction MedsAlcoholDisordersMed-PsychResearchSubstance Use

How to Personalize Meds for Alcohol Use Disorder

July 23, 2026by Chris Aiken, MD0
Buprenorphine vs Naltrexone: A Large Study
Addiction MedsMedicationsOpioidsResearchSubstance Use

Buprenorphine vs Naltrexone: A Large Study

July 15, 2026by Chris Aiken, MD0
Matching Opioid MAT for Complex Patients
Addiction MedsDisordersMed-PsychOpioidsResearchSubstance Use

Matching Opioid MAT for Complex Patients

July 10, 2026by Chris Aiken, MD0
Buprenorphine and Naltrexone for Impaired Physicians
AlcoholOpioidsResearchSubstance Use

Buprenorphine and Naltrexone for Impaired Physicians

June 17, 2026by Chris Aiken, MD0
Topiramate and Naltrexone Reduce Alcohol Through Common Mechanism
AlcoholMedicationsResearchSubstance Use

Topiramate and Naltrexone Reduce Alcohol Through Common Mechanism

June 9, 2026by Chris Aiken, MD0
FDA Moves the Goalposts on Alcohol Treatment
Addiction MedsAlcoholResearchSubstance Use

FDA Moves the Goalposts on Alcohol Treatment

June 2, 2026by Chris Aiken, MD0
A GLP-1 Trial Changes the Score in Alcohol, With a Catch
AlcoholGLP1 AgonistsMedicationsResearchResearch for the PublicSubstance UseTop Research

A GLP-1 Trial Changes the Score in Alcohol, With a Catch

May 5, 2026by Chris Aiken, MD0
Naltrexone-Baclofen Combo for Alcohol Craving
Addiction MedsAlcoholMedicationsResearchSubstance UseTop Research

Naltrexone-Baclofen Combo for Alcohol Craving

April 28, 2026by Chris Aiken, MD1
Low Dose Naltrexone in Depression
Addiction MedsDepressionInflammationResearch

Low Dose Naltrexone in Depression

March 23, 2026by Chris Aiken, MD0
Top Studies
All Studies
Self Help
Become a Therapy Partner

Recent Posts

  • October 22, 2026High IQ and ADHD: Less Inattention, More Impulsivity?

  • October 20, 2026Risperidone for Aggression in ADHD

  • October 20, 2026Saffron for ADHD: A Small Trial

  • October 19, 2026Mild ADHD Causes a Major Problem

  • October 17, 2026ADHD Raises Risk for Psychotic Disorders

Categories

  • Addiction Meds
  • ADHD
  • Alcohol
  • Antidepressants
  • Antipsychotics
  • Anxiety
  • Autism
  • Benzodiazepines
  • Bipolar
  • Bipolar Meds
  • Cannabis
  • Child Psychiatry
  • Clozapine
  • Cocaine
  • Cognition
  • Dementia
  • Deprescribing
  • Depression
  • Devices
  • Difficult to Treat Depression
  • Disorders
  • Eating Disorders
  • ECT
  • Exercise
  • Geriatric Psychiatry
  • GLP1 Agonists
  • Hypnotics
  • Inflammation
  • Ketamine
  • Lifestyle
  • Light Therapy
  • Lithium
  • Med-Psych
  • Medications
  • Methamphetamine
  • Neuromodulation/TMS
  • Nutrition
  • OCD
  • Opioids
  • Personality Disorders
  • Psychedelics
  • PTSD
  • Research
  • Research for the Public
  • Schizophrenia and Psychosis
  • Sedatives
  • Sexual dysfunction
  • Side Effects
  • Sleep
  • Stimulants
  • Substance Use
  • Supplements
  • Therapy
  • Top Research
  • Uncategorized
  • Women's Health
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_02.png?fit=161%2C245&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_03.png?fit=84%2C96&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_10.png?fit=75%2C84&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/SquareLogoMediumThumn-min.jpg?resize=160%2C160&ssl=1

Collaborative mental health

©2025 Psych Partners USA | Terms of use | Cookie policy

Career opportunities
Chris Aiken, MD
LINKS
  • About us
    • Chris Aiken, MD
    • Team
    • Contact
    • Locations
ADMINISTRATIVE TEAM

Nancy Brandon,
Director of Operations

2016 Ashburn Lane
Clemmons, NC 27012

(336) 948-1876

nancy.brandon@psych-partners.com

ADMIN HOURS

Mon – Fri: 9am-5pm EST
Sat – Sun: Closed

bt_bb_section_top_section_coverage_image